NCT04840420

Brief Summary

This research is an effectiveness-implementation hybrid study with two aims: 1\) to determine the utility of a WBC (Well Being Coordinator)-driven Social Prescribing model in the intermediate care setting; and 2) to assess the patient health outcomes associated with the implementation pilot. The implementation research questions include:

  1. 1.Practical fit: Does the intervention fit with the daily life activities of study participants? What is the level of safety and burdensomeness of the frequency, intensity and duration of the intervention?
  2. 2.Acceptability: What are the acceptance, retention and follow-up rates as the participants move through the intervention? What are the reasons for retention?
  3. 3.Adoption: How well do the WBC carry out the assessment and intervention as planned?
  4. 4.Participants in the intervention group will incur a higher improvement in perceived general wellbeing and social support than those participants in the control group.
  5. 5.Participants in the intervention group will incur less healthcare utilisation than those in the control group.
  6. 6.Improvement in the perceived general wellbeing and social support will be moderated by the level of social support of participants.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
804

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Apr 2021

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 7, 2021

Completed
5 days until next milestone

First Posted

Study publicly available on registry

April 12, 2021

Completed
7 days until next milestone

Study Start

First participant enrolled

April 19, 2021

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2022

Completed
Last Updated

April 12, 2021

Status Verified

April 1, 2021

Enrollment Period

1.4 years

First QC Date

April 7, 2021

Last Update Submit

April 8, 2021

Conditions

Keywords

well-being coordinatorssocial prescribing

Outcome Measures

Primary Outcomes (2)

  • BIT score

    general wellbeing measured by the Brief Inventory of Thriving (BIT),

    2 months post discharge

  • mMOS-SS score

    social support will be measured by the modified Medical Outcomes Study \- Social Support Survey (mMOS-SS)

    2 months post discharge

Secondary Outcomes (3)

  • healthcare utilisation 12months post enrollment

    12 months post enrollment

  • MBI

    1 day to 6 months post enrollment

  • qualitative study

    1 day to 12 months post enrollment

Study Arms (2)

Intervention

ACTIVE COMPARATOR

Inpatient The WBCs conducts approximately daily visits to: 1. collect demographics and baseline data; 2. co-develop personalised social prescription plan with the participant based on Social Determinants of Health (SDoH) using SBAR4; 3. referring and accompanying the participant to attend inpatient activities that suit the participant's interests and preferences; and 4. informing and seeking the participant's agreement with community assets identified for the participant together with CNS. About 1-week post-discharge, the WBCs will call to check his/her transition back to community and readiness to start attending community activities or receiving services. For community activities, the WBCs and CNS will visit the participant, accompanying him/her to the activity premise on the first day of the activity session and send the participant home after the session.

Other: social prescribing

Control

OTHER

Usual Care Inpatient phase For the control group, the interviewer will conduct approximately 2 visits to collect demographics and baseline data. The duration of each visit will range from 15 to 30 minutes. Community phase For the control group, no intervention will be administered.

Other: usual care

Interventions

as above

Intervention

as above

Control

Eligibility Criteria

Age21 Years - 99 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • the study team uses 7 categories of SDOH, namely Housing, Food, Economic Stability, Cognition and Learning, Social Environment, Access to Healthcare, and Digital Technologies. If there are care needs related to at least one category of SDOH, the patients will be deemed eligible for the Social Prescribing intervention. In addition, the patient must have the mental capacity to consent and participant in thesurvey.

You may not qualify if:

  • The following group of patients will be excluded from the study:
  • Patients who will be discharged to Nursing Homes;
  • Patients who are unable to complete the required survey used in this study due to physical/sensory/cognitive impairment; and/or
  • Patients who are diagnosed with a life-limiting condition with a prognosis of equal or less than 3 months.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (2)

  • Polley MJ, Fleming J, Anfilogoff T, Carpenter A. Making sense of Social Prescribing. Univ Westminst. Published online August 17, 2017:79.

    BACKGROUND
  • Helen J. Chatterjee, Paul M. Camic, Bridget Lockyer & Linda J. M. Thomson (2018) Non-clinical community interventions: a systematised review of social prescribing schemes, Arts & Health, 10:2, 97-123, DOI:10.1080/17533015.2017.1334002

    BACKGROUND

MeSH Terms

Conditions

Social Isolation

Condition Hierarchy (Ancestors)

Social BehaviorBehavior

Study Officials

  • Lee Kheng Hock, MBBS

    Bright Vision Hospital

    PRINCIPAL INVESTIGATOR
  • Low Sher Guan, MBBS

    Sengkang Community Hospital

    STUDY DIRECTOR
  • Low Lian Leng, MBBS

    Outram Community Hospital

    STUDY DIRECTOR
  • Kwan Li Feng, Adeline

    Sengkang Community Hospital

    STUDY DIRECTOR
  • Zhao Dan

    Sengkang Community Hospital

    STUDY DIRECTOR
  • Wong Peng Yong, Andrew, MBBS

    Bright Vision Hospital

    STUDY DIRECTOR

Central Study Contacts

Wong Peng Yong, Andrew, MBBS

CONTACT

Png Shi Hui, Noelle

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: open label randomised control trial
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 7, 2021

First Posted

April 12, 2021

Study Start

April 19, 2021

Primary Completion

September 30, 2022

Study Completion

September 30, 2022

Last Updated

April 12, 2021

Record last verified: 2021-04

Data Sharing

IPD Sharing
Will not share